Literature DB >> 17805935

Combined resection of the pancreas and inferior vena cava for pancreatic metastasis from renal cell carcinoma.

J J Tuech1, B Lefebure, V Bridoux, B Albouy, E Lermite, F Le Pessot, I Le Blanc-Louvry, F Michot.   

Abstract

Indications for pancreatic resections for metastatic disease have not yet been defined to date, and few guidelines exist for the management of these lesions. However, most authors recommend surgery as the treatment of choice for pancreatic metastasis (PM). Resection of the inferior vena cava (IVC) is rarely done during removal of peripancreatic cancer. This report presents the first case of metachronous PM from renal cell carcinoma (RCC) with IVC involvement successfully treated by en-bloc resection in a 70-year-old asymptomatic woman. The abdominal computed tomography (CT) scan showed a 4.0-cm mass in the tail and a 5.0-cm mass in the head of the pancreas with a suspected involvement of vena cava. An en-bloc total pancreatectomy was performed with excision of the involved portion of the cava vein. Histology confirmed the presence of two metastases from RCC with neoplastic infiltration of the IVC and without lymph node involvement. All surgical margins were tumor-free. At most recent follow-up 12 months after pancreatectomy, the patient has no evidence of disease. We believe that a multidisciplinary approach and careful evaluation and treatment of these patients is a mandatory component for patient selection. IVC resection should be performed only when a margin-negative resection is expected to be achieved.

Entities:  

Mesh:

Year:  2007        PMID: 17805935     DOI: 10.1007/s11605-007-0295-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

1.  Renal function is well maintained after use of left renal vein graft for vascular reconstruction in hepatobiliary-pancreatic surgery.

Authors:  Takeshi Suzuki; Hiroyuki Yoshidome; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Atsushi Kato; Hideyuki Yoshitomi; Satoshi Nozawa; Shigeaki Sawada; Masaru Miyazaki
Journal:  J Am Coll Surg       Date:  2005-10-13       Impact factor: 6.113

Review 2.  Combined hepatic and vena caval resection with autogenous caval graft replacement.

Authors:  C M Miller; M E Schwartz; T Nishizaki
Journal:  Arch Surg       Date:  1991-01

3.  Segmental resection and reconstruction of the inferior vena cava with an autogenous vein graft.

Authors:  H Yamamoto; N Hayakawa; A Ogawa; E Sakamoto; M Nagino; J Kamiya; Y Nimura
Journal:  Br J Surg       Date:  1997-01       Impact factor: 6.939

Review 4.  Pancreaticoduodenectomy for metastatic renal cell carcinoma: report of a case.

Authors:  N Mehta; C Volpe; T Haley; L Balos; E L Bradley; R J Doerr
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  Portal vein reconstruction at the hepatic hilus using a left renal vein graft.

Authors:  M Miyazaki; H Itoh; T Kaiho; S Ambiru; A Togawa; K Sasada; M Shiobara; Y Shimizu; S Yoshioka; H Yoshitome
Journal:  J Am Coll Surg       Date:  1995-04       Impact factor: 6.113

6.  Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors.

Authors:  J Le Borgne; C Partensky; P Glemain; B Dupas; B de Kerviller
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

Review 7.  Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature.

Authors:  Moritz N Wente; Jörg Kleeff; Irene Esposito; Mark Hartel; Michael W Müller; Boris E Fröhlich; Markus W Büchler; Helmut Friess
Journal:  Pancreas       Date:  2005-04       Impact factor: 3.327

8.  Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival.

Authors:  J P Faure; J J Tuech; J P Richer; P Pessaux; J P Arnaud; M Carretier
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

9.  Multiple late asymptomatic pancreatic metastases from renal cell carcinoma: diagnosis by endoscopic ultrasound-guided fine needle aspiration biopsy with immunocytochemical correlation.

Authors:  Mohamad A Eloubeidi; Darshana Jhala; David C Chhieng; Nirag Jhala; Isam Eltoum; C Mel Wilcox
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

10.  Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy?

Authors:  Juan M Sarmiento; Thomas C Bower; Kenneth J Cherry; Michael B Farnell; David M Nagorney
Journal:  Arch Surg       Date:  2003-06
View more
  7 in total

1.  Unexpected Prolonged Survival After Extended and Emergent Resection of Pancreatic Metastases from Renal Cell Carcinoma.

Authors:  Stefania Brozzetti; Antonio V Sterpetti
Journal:  J Gastrointest Cancer       Date:  2019-12

Review 2.  Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?

Authors:  Franz Sellner
Journal:  Clin Exp Metastasis       Date:  2018-06-12       Impact factor: 5.150

3.  Pancreatic metastases: An increasing clinical entity.

Authors:  Alessandro Zerbi; Nicolò Pecorelli
Journal:  World J Gastrointest Surg       Date:  2010-08-27

Review 4.  Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism?

Authors:  Franz Sellner
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

5.  Laparoscopic total pancreatectomy for multiple metastasis of renal cell carcinoma of the pancreas: a case report and literature review.

Authors:  Yun Jong Choi; Jin Ho Lee; Cho Rok Lee; Woong Kyu Han; Chang Moo Kang; Woo Jung Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-05-23

Review 6.  Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations.

Authors:  Franz Sellner
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

Review 7.  Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity.

Authors:  Franz Sellner; Sabine Thalhammer; Martin Klimpfinger
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.